comparemela.com

Latest Breaking News On - பலா வாண்டன் ெவேல் - Page 1 : comparemela.com

INDIGO Biosciences Announces Addition of TPOR Assay to Pre-Clinical Portfolio

State College (PRWEB) August 10, 2021 INDIGO Biosciences, the recognized industry leader in nuclear receptor research, has expanded its pre-clinical

INDIGO Biosciences Expands Preclinical Portfolio for Anemia and Oncology Research

INDIGO Biosciences Expands Preclinical Portfolio for Anemia and Oncology Research Share Article Erythropoietin Receptor Assay Targets Red Blood Cell Development and Production “The addition of EPOR to INDIGO’s portfolio expands our understanding of red blood cell production as it relates to both beneficial and harmful downstream effects in other areas of disease state development.” STATE COLLEGE, Pa. (PRWEB) April 20, 2021 INDIGO Biosciences, the recognized industry leader in nuclear receptor research, has expanded their robust preclinical testing portfolio to include a new Erythropoietin Receptor (EPOR) assay primarily used in the treatment of anemia and implicated in the development of certain cancers. This cell-based in vitro assay provides discovery researchers with the ability to quickly make critical decisions about potential drug candidates before moving into trials.

INDIGO Biosciences Expands Autoimmune-Focused Preclinical Testing Portfolio

INDIGO Biosciences Expands Autoimmune-Focused Preclinical Testing Portfolio Share Article Nuclear Factor of Activated T cells Assay Targets Preclinical Autoimmune and Oncology Research The addition of NFAT to our portfolio expands opportunities for autoimmune and oncology researchers to get the critical interaction and activation data they need, before entering costly clinical trials. STATE COLLEGE, Pa. (PRWEB) March 16, 2021 INDIGO Biosciences, the recognized industry leader in nuclear receptor research, has expanded their robust testing portfolio to include a new Nuclear Factor of Activate T cells (NFAT) assay used primarily for preclinical autoimmune research. This cell-based in vitro assay provides discovery researchers with the ability to quickly make critical decisions about potential drug candidates before moving into trials. NFAT is also implicated in the development of several diseases, including infl

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.